Status:
TERMINATED
Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy
Lead Sponsor:
Parc Taulí Hospital Universitari
Collaborating Sponsors:
Consorci Sanitari de Terrassa
Hospital Mutua de Terrassa
Conditions:
Colorectal Cancer
Colon Polyp
Eligibility:
All Genders
50-69 years
Phase:
NA
Brief Summary
One tricky aspect of the recommendations for colonoscopy prep is diet. This has a significant impact on the experience of the patient or participant in the screening program and, on the other hand, lo...
Eligibility Criteria
Inclusion
- Men and women between 50 and 69 years old.
- Participants in the Program for the Early Detection of Colorectal Cancer with a positive result in the test for detecting occult blood in feces
- That they accept a colonoscopy and that they agree to participate in the study.
Exclusion
- Contraindication to performing a colonoscopy.
- Severe renal insufficiency (\<30 ml / min).
- Known hypersensitivity or allergy to polyethylene glycol, ascorbic acid or sulfate.
- Known glucose-6-phosphate dehydrogenase deficiency.
- Known phenylketonuria.
- Known dyselectrolytemia: hyper / hyponatremia, hyperphosphatemia, hypermagnesemia, hyper / hypokalemia, hypocalcemia.
- Gastric emptying disorders: Known gastroparesis.
- Known hypoalbuminemia less than 3.4 g / dl.
- Crohn's disease or known ulcerative colitis.
- Participants with difficult-to-control hypertension (SBP\> 170mmHg or TAD\> 100mmHg) or NYHA grade III or IV heart failure.
- Ascites of any etiology
- People with cognitive impairment or mental illness that makes it difficult to adhere to instructions.
- People who do not understand Catalan or Spanish.
- Factors of poor preparation: liver cirrhosis, diabetes mellitus, treatment with tricyclic antidepressants, opioids or neuroleptics, limited mobility, chronic constipation, history of colon or intestinal resection (appendectomy is not an exclusion criterion), poor preparation in previous colonoscopy Parkinson's disease, multiple sclerosis.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04664543
Start Date
December 1 2019
End Date
December 30 2020
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain, 08208